Clik here to view.
You Heard It Here First: Sept. 30, 2016, Is the Date to Watch
Sept. 30, 2016 is the date to watch… Eight must-know questions about SDRs… A major trend that could disrupt too-big-to-fail banks… And more! The post You Heard It Here First: Sept. 30, 2016, Is the...
View ArticleClik here to view.
Last Chance At the Steal of the Century
The real estate steal you couldn’t get in 2012... only now we’ve found a back door in 2015, and it’s not too late The post Last Chance At the Steal of the Century appeared first on Agora Financial.
View ArticleClik here to view.
The “There-Must-Be-a-Pony” Effect and My Top 5 Picks
The mailbag, including my top five picks for new money, and I want to take you on a brief digression on the nature of news and knowledge. The post The “There-Must-Be-a-Pony” Effect and My Top 5 Picks...
View ArticleClik here to view.
How Hillary Clinton Sparked a Biotech Bear Market
It’s no secret that the stock market has gone through a rough patch lately. However, it’s especially important to recognize the changes in character we’ve seen in former leader like biotech stocks....
View ArticleClik here to view.
Another “Silver Bullet” Trade Gives Us an Extra $350 in Instant Income
Each week, we get paid to enter our agreement to potentially buy shares of stock at a cheaper price. For income investors, our strategy is a win-win opportunity. Either we keep our income and buy...
View ArticleClik here to view.
New Buy Triggered: The (Un)Magnificent Seven
A rolling crisis is battering emerging-market stocks. Mexico won’t avoid the pain... And we have a put option that could soar 370%. The post New Buy Triggered: The (Un)Magnificent Seven appeared first...
View ArticleClik here to view.
“Generic Bioequivalence” and Outrageous Profits
The real story behind the $13.50 pill that’s now $750, and the investing takeaway the financial media won’t tell you The post “Generic Bioequivalence” and Outrageous Profits appeared first on Agora...
View ArticleClik here to view.
The “Worst Meltdown Since 2008”— and It’s Not Over Yet…
This year’s big market meltdown comes courtesy of commodities. And it’s not just crude or gold or even copper right now, the usual suspects we talk about around here. This disease has metastasized...
View ArticleClik here to view.
Bonus Trade Alert: Collect an Instant $440 Today. Plus, an Important Reminder
The decline in U.S. oil production has created an opportunity. Zach gives you the skinny on how to profit from it. Also in this alert is an exclusive invitation to learn more about income payments from...
View ArticleClik here to view.
Updates: One to SELL and One to HOLD
This week, the markets saw biotech stocks thrown into turmoil. So I wanted to give you an update on why we are still long and strong on this biotech play. But it’s time to sell out of this Chinese...
View ArticleClik here to view.
Special Alert: How Much to Pay for Our Small Stem Cell Company With Promise
I believe that if you want to undertake this extremely risky investment with a huge potential for gains (or huge losses), you should buy in now. The post Special Alert: How Much to Pay for Our Small...
View ArticleClik here to view.
Midweek Briefing — Shale’s Next Trick… “Re-Fracking”
Less than 10%. I’m referring to the amount of oil or natural gas in the ground that a typical shale well recovers. That means that more than 90% of the hydrocarbons that are trapped in the rocks are...
View ArticleClik here to view.
Your Six-Month Outlook
What the Chinese president said… and what he meant. Plus Jim Rickards on the state of play between China and the U.S…and why the next six months will feel much like the last six The post Your Six-Month...
View ArticleClik here to view.
Watch List: 2 Turnaround Trades
Turnaround trades can be extremely powerful moves as they shift from underperforming to making up for lost time – and that's good reason to keep an eye on these two setups. The post Watch List: 2...
View ArticleClik here to view.
Watch List: 2 Turnaround Trades
Turnaround trades can be extremely powerful moves as they shift from underperforming to making up for lost time – and that's good reason to keep an eye on these two setups. The post Watch List: 2...
View ArticleClik here to view.
Locking in a 36% Profit From This Activist Investor Target
Activist investors and company turnarounds can be a winning combo. Zach found such a situation for you. Now it’s time to collect. The post Locking in a 36% Profit From This Activist Investor Target...
View ArticleClik here to view.
The Bull’s Broken — Here’s What Happens Now…
Listen, we just recently experienced 47 months where the market didn’t offer up a 10% correction. That’s incredible. And now that stocks are moving lower, you might feel some discomfort. It could take...
View ArticleClik here to view.
What Happened With Our Cancer Play (and What to Do About It)
It's important to remember that even as we wait for a big catalyst to play out in a biotechnology trade, other events can significantly move a company's share price. The post What Happened With Our...
View ArticleClik here to view.
Bulldozers, Biotech and Banksters
Three reasons Caterpillar is kicking 5,000 people to the curb. Plus: Biotech on the cusp of a bear market… but not if you choose wisely. And bankster logic: The economy doesn’t suck, because iPhones...
View ArticleClik here to view.
Your Burger Chain Operator Hits an All-Time High!
It’s been yet another sloppy week in the market. There is one bright spot, however. One of our microcap picks just hit an all-time high this week. We’re up over 90% on this one since October 2014....
View Article